Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

B Osterud, S I Rapaport
PMCID: PMC431674  PMID: 271951

Abstract

A study was carried out on mechanisms, independent of activated Factor XI, capable of activating Factor IX. The reaction product of tissue factor and Factor VII functioned as a potent Factor IX activator in the assay system used. Activated Factor IX itself activated Factor X; thrombin failed to activate Factor IX. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis confirmed that the reaction product of tissue factor and Factor VII activated Factor IX, with replacement of the band corresponding to native factor IX [molecular weight (Mr) 55,000] by bands corresponding to the heavy chain (Mr 27,000) and light chain (Mr 17,000) of activated Factor IX. When either Factor VII or calcium ions were left out of incubation mixtures, the band of native Factor IX persisted unchanged. Contact of blood with tissue factor represents a second mechanism, bypassing activated Factor XI, for the activation of Factor IX during hemostasis. It may help to explain the discrepancy between the mild bleeding of hereditary Factor XI deficiency and the severe bleeding of hereditary Factor IX deficiency.

Full text

PDF
5260

Images in this article

5263Image
on p.5263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  2. Fujikawa K., Legaz M. E., Kato H., Davie E. W. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry. 1974 Oct 22;13(22):4508–4516. doi: 10.1021/bi00719a006. [DOI] [PubMed] [Google Scholar]
  3. Fujikawa K., Thompson A. R., Legaz M. E., Meyer R. G., Davie E. W. Isolation and characterization of bovine factor IX (Christmas factor). Biochemistry. 1973 Nov 20;12(24):4938–4945. doi: 10.1021/bi00748a019. [DOI] [PubMed] [Google Scholar]
  4. Josso F., Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh Suppl. 1965;17:35–44. [PubMed] [Google Scholar]
  5. Kalousek F., Konigsberg W., Nemerson Y. Activation of factor IX by activated factor X: a link between the extrinsic and intrinsic coagulation systems. FEBS Lett. 1975 Feb 15;50(3):382–385. doi: 10.1016/0014-5793(75)80533-3. [DOI] [PubMed] [Google Scholar]
  6. Kasper C. K., Osterud B., Minami J. Y., Shonick W., Rapaport S. I. Hemophilia B: characterization of genetic variants and detection of carriers. Blood. 1977 Sep;50(3):351–366. [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Orstavik K. H., Osterud B., Prydz H., Berg K. Electroimmunoassay of factor IX in hemophilia B. Thromb Res. 1975 Sep;7(3):373–382. doi: 10.1016/0049-3848(75)90031-6. [DOI] [PubMed] [Google Scholar]
  9. Osterud B., Berre A., Otnaess A. B., Bjorklid E., Prydz H. Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry. 1972 Jul 18;11(15):2853–2857. doi: 10.1021/bi00765a018. [DOI] [PubMed] [Google Scholar]
  10. Osterud B., Flengsrud R. Purification and some characteristics of the coagulation factor IX from human plasma. Biochem J. 1975 Mar;145(3):469–474. doi: 10.1042/bj1450469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Osterud B., Rapaport S. I., Lavine K. K. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood. 1977 May;49(5):819–834. [PubMed] [Google Scholar]
  12. Osterud B., Schiffman S. Gel filtration properties of factors II, VII, IX, IX a , and X. Thromb Diath Haemorrh. 1972 Oct 31;28(2):317–324. [PubMed] [Google Scholar]
  13. RAPAPORT S. I., SCHIFFMAN S., PATCH M. J., AMES S. B. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood. 1963 Feb;21:221–236. [PubMed] [Google Scholar]
  14. Rapaport S. I., Hjort P. F., Patch M. J., Jeremic M. Consumption of serum factors and prothrombin during intravascular clotting in rabbits. Scand J Haematol. 1966;3(1):59–75. doi: 10.1111/j.1600-0609.1966.tb00626.x. [DOI] [PubMed] [Google Scholar]
  15. Schiffman S., Theodor I., Rapaport S. I. Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry. 1969 Apr;8(4):1397–1405. doi: 10.1021/bi00832a014. [DOI] [PubMed] [Google Scholar]
  16. Thompson A. R., Davie E. W. Affinity chromatography of thrombin. Biochim Biophys Acta. 1971 Oct;250(1):210–215. doi: 10.1016/0005-2744(71)90136-7. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES